Janux Therapeutics Inc (JANX)
50.47
+3.97
(+8.54%)
USD |
NASDAQ |
Nov 22, 16:00
50.47
0.00 (0.00%)
After-Hours: 17:37
Janux Therapeutics Shareholders Equity (Quarterly): 656.10M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 656.10M |
| June 30, 2024 | 657.68M |
| March 31, 2024 | 655.76M |
| December 31, 2023 | 344.35M |
| September 30, 2023 | 348.95M |
| June 30, 2023 | 299.47M |
| March 31, 2023 | 311.26M |
| December 31, 2022 | 320.74M |
| Date | Value |
|---|---|
| September 30, 2022 | 331.51M |
| June 30, 2022 | 343.81M |
| March 31, 2022 | 356.08M |
| December 31, 2021 | 366.33M |
| September 30, 2021 | 376.75M |
| June 30, 2021 | 384.80M |
| March 31, 2021 | -16.77M |
| December 31, 2020 | -14.64M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-16.77M
Minimum
Mar 2021
657.68M
Maximum
Jun 2024
357.64M
Average
346.65M
Median
Shareholders Equity (Quarterly) Benchmarks
| Dynavax Technologies Corp | 681.43M |
| Krystal Biotech Inc | 885.85M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
| iBio Inc | 17.75M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 695.02M |
| Total Liabilities (Quarterly) | 38.92M |
| Current Ratio | 38.80 |